Abbott Laboratories Cartridge Gets FDA Clearance to be Used with Whole Blood
By Denny Jacob
Abbott Laboratories' i-STAT TBI cartridge received clearance from the Food and Drug Administration to be used with whole blood, offering an additional tool for people with suspected concussions.
The healthcare-products manufacturer said the cartridge's ability to use whole blood will provide lab-quality results in 15 minutes.
Abbott said the clearance will enable testing in new healthcare settings beyond hospital emergency departments including urgent care clinics with a certificate to perform moderate complexity tests.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
April 01, 2024 09:34 ET (13:34 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks